Oncology Specialists, S.C.

1700 Luther Ln Ste 2200, Park Ridge, Illinois, United States

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

63.6%

Phase 1

27.3%

Trial Status Distribution

Completed

72.7%

Terminated

27.3%

Clinical Trials

Trials sponsored by this organization (11)

Patients With Relapsed or Refractory Diffuse Large B Cell Non Hodgkin Lymphomas

Phase 2

Terminated

interventional

Feb 201011 participants

Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients

Phase 2

Completed

interventional

Jun 200921 participants

Non-Hodgkin Lymphoma in Elderly Patients Above the Age of 80 in the Rituximab Era

Completed

observational

May 200950 participants

Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients

Phase 2

Completed

interventional

Feb 200832 participants

Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC)

Phase 1

Completed

interventional

Jan 200717 participants

Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer

Phase 1

Completed

interventional

Dec 200622 participants

VELCADE,Rituximab,Cyclophosphamide and Decadron

Phase 2

Terminated

interventional

Aug 200612 participants

GM-CSF for Maintenance of Prostate Cancer for Patients Responding to Taxotere

Phase 2

Completed

interventional

Jan 200615 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations